Despite these advances, there are certain types of cancer that defy diagnosis and often carry a particularly grim prognosis. Pancreatic, ovarian, and lung cancers fall into this category. Reasons for a delay in the diagnosis of cancer include:
- Inadequate access to medical care
- Lack of noticeable signs or symptoms in the early stages of certain cancers
- Failure to seek medical attention for signs or symptoms suggesting cancer
- Delayed diagnosis because of cancer signs or symptoms mimicking another illness
- Absence of effective screening tests for certain cancers
- Cancers “hidden” in organs that are not easily examined
What can be done to improve early detection? All of the cancers mentioned above can be diagnosed through physical exams and medical tests such as CT scans, MRIs, blood tests and ultrasounds. The specific diagnostic tests will vary depending on the type of cancer.
In regard to ovarian cancer, two tests, the transvaginal ultrasound and a blood test called CA-125, have been used to detect ovarian cancer. Currently, however, they are not recommended as a screening test for women in the general population since they have not been shown to reduce mortality. Women are encouraged to report symptoms associated with ovarian cancer to their doctor for further evaluation. These symptoms include abdominal swelling or bloating (due to a mass or a buildup of fluid), pelvic pressure or abdominal pain, difficulty eating or feeling full quickly, and/or urinary symptoms (having to go urgently or often).
Approximately 85% of lung cancer develops in former or current smokers. Screening for lung cancer is also not recommended for the general population. In high risk individuals (adults aged 55 to 80 years who have a significant smoking history and currently smoke or have quit within the past 15 years), however, the US Preventive Services Task Force recommends annual screening for lung cancer with low-dose computed tomography (CT scan).
Pancreatic cancer remains one of the most deadly forms of cancer with very little improvement in mortality rate over the past several decades. There are two cancer “markers” that can be detected with blood tests (CA19-9 and CEA). These tests, however, are not consistently positive even when pancreatic cancer is present and are not recommended as a screening test. Typically only vague symptoms that could be associated with several different gastrointestinal conditions are present when pancreatic cancer is suspected. These include pain (usually abdominal or back pain), weight loss, jaundice (yellowing of the skin and eyes), loss of appetite, nausea, and changes in stool.
With most of these difficult-to-diagnose cancers it appears that the best way toward early diagnosis is to be aware of changes in your body and discuss any troubling signs or symptoms with your doctor. More often than not, these new complaints will have nothing to do with cancer and can be treated or will resolve on their own. When persistent symptoms suggest cancer, however, making the diagnosis as early into its course as possible can lead to a much improved outcome.
If you have any questions about cancer diagnosis, please log into your account and send us your question. We are here to help.